NCT Number: NCT00999063
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with GerdQ Thai Version.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Research Site, Bangkok Noi, Bangkok, Thailand
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Provision of informed consent prior to any study specific procedures
- Female or male aged at least 18 years
- Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation
Exclusion criteria
- Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site
- Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months
Treatment and study plan
Primary outcomes
-
Prevalence of gastroesophageal reflux disease (GERD) in patients presented with upper gastrointestinal tract symptoms
Secondary outcomes
-
Response to various treatments for patients who have been diagnosed of GERD
Sponsors and collaborators
Lead sponsor
AstraZeneca
Industry
Registry information
Official study title
Prevalence of GERD in Patients With upperGITsymptoms in Thailand
Acronym: GerdQ
Important dates
- Study start
- 2009
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- Oct 21, 2009
- Registry last updated
- Mar 31, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.